-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Jw2Hco4sZqm+gDdXahGGfImGcKwZ+v8Trzgajj3cCNB4h0YYzTN4ClVBuJn31PaR OWZ0/aRwUhB3yGn8vm69/A== 0000891618-03-006205.txt : 20031208 0000891618-03-006205.hdr.sgml : 20031208 20031208165422 ACCESSION NUMBER: 0000891618-03-006205 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031205 ITEM INFORMATION: Changes in registrant's certifying accountant FILED AS OF DATE: 20031208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STEMCELLS INC CENTRAL INDEX KEY: 0000883975 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943078125 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19871 FILM NUMBER: 031042960 BUSINESS ADDRESS: STREET 1: 3155 PORTER DRIVE STREET 2: . CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 6504753100 MAIL ADDRESS: STREET 1: 3155 PORTER DRIVE STREET 2: . CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: CYTOTHERAPEUTICS INC/DE DATE OF NAME CHANGE: 19930328 8-K 1 f95024e8vk.htm FORM 8-K StemCells, Inc. Form 8-K Dated 12/5/2003
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) December 05, 2003

STEMCELLS, INC.

(Exact name of registrant as specified in its charter)
         
Delaware   0-19871   95-3078125
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

3155 Porter Drive
Palo Alto, California 94304
(Address of principal executive offices, including zip code)

(650) 475-3100
(Registrant’s telephone number, including area code)

 

Item 4. Changes in Registrant’s Certifying Accountant
Signature

Table of Contents

Item 4. Changes in Registrant’s Certifying Accountant

New Independent Public Accountants

     On December 08, 2003, the Company engaged Grant Thornton LLP as its independent public accountants. The Company’s audit committee and board of directors independently approved resolutions on November 17, 2003 and November 20, 2003, respectively, approving the selection of Grant Thornton LLP.

     During the Company’s two most recent fiscal years ended December 31, 2002 and the subsequent interim periods through the engagement of Grant Thornton LLP, the Company has not consulted with Grant Thornton LLP regarding either the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, or any matter that was the subject of a disagreement, within the meaning of Item 304(a)(1)(iv) of Regulation S-K, or a reportable event, as described in the Item 304(a)(1)(v) of Regulation S-K.

2

Table of Contents

Signature

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
    StemCells, Inc.
         
    By:   /s/ Martin McGlynn
       
        Martin McGlynn
        President and Chief Executive Officer

Date: December 08, 2003

3

-----END PRIVACY-ENHANCED MESSAGE-----